The latest in clinical trial results of 5-alpha reductase inhibitors in combination regimens for benign prostatic hyperplasia.
Kapriniotis K, Manolitsis I, Juliebo-Jones P, Pietropaolo A, Tsaturyan A, Tonyali S, Sener E, Emiliani E, Talyshinskii A, Karagiotis T, Somani B, Tzelves L.
Kapriniotis K, et al. Among authors: karagiotis t.
Expert Opin Pharmacother. 2025 Jan 15:1-11. doi: 10.1080/14656566.2025.2453586. Online ahead of print.
Expert Opin Pharmacother. 2025.
PMID: 39801071
Review.